Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants. - Wikidata - awgldk - TriplyDB

Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.

Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.

http://www.wikidata.org/entity/Q35601036

about

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Network-based biomarkers in Alzheimer's disease: review and future directions Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics Anti-aggregating effect of the naturally occurring dipeptide carnosine on aβ1-42 fibril formation Chronic traumatic encephalopathy: a critical appraisal.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer's disease.Soluble amyloid-β levels and late-life depression The future of blood-based biomarkers for Alzheimer's disease.Activation of the factor XII-driven contact system in Alzheimer's disease patient and mouse model plasma.Will posttranslational modifications of brain proteins provide novel serological markers for dementias?Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes.Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression?The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.Advances in blood-based protein biomarkers for Alzheimer's disease Association of plasma and cortical amyloid beta is modulated by APOE ε4 status Progress update: fluid and imaging biomarkers in Alzheimer's disease.Plasma biomarkers for Alzheimer's disease: much needed but tough to find.Amyloid-β as a biomarker for Alzheimer's disease: quantification methods in body fluids.The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer's disease.Early-life disruption of epigenetic marks may contribute to the origins of mental illness.Donepezil modulates the endogenous immune response: implications for Alzheimer's disease.Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.A novel detection method of cleaved plasma high-molecular-weight kininogen reveals its correlation with Alzheimer's pathology and cognitive impairment

P2860

Q27006831-648645C8-E5E9-470E-AFB3-29363F5011CC Q27023864-D84A7A6D-FDC8-4456-B8D2-F5FDD3F85771 Q27024518-9365BBAB-CBA0-420A-903E-2277F2C85205 Q28534489-DEB8B7AE-CF63-4BED-9B46-56BF9D219AB9 Q30688850-6A5117C6-97B7-4286-9AFE-D438A2D29027 Q30971403-EDC3FE3C-1C86-453C-9726-A7FD2D992F3D Q33745617-BEBC5AB3-405D-4120-89AE-F9917122770F Q33895177-3B6D1E03-448B-46CA-A48F-A155CC808A31 Q33933220-07FBAD58-8D1E-4226-A372-125559815FBA Q34026317-395B214E-F92D-4B8F-9446-A016D0F5584F Q35279729-A66BE50C-0684-4F8E-BD96-A6EF98AC1654 Q36072517-C4272267-2BFA-4881-9976-F7E218EC155D Q36687762-C0C2EBFA-48A1-47C3-9504-CD7B91DD99D7 Q36711795-893B07BC-D7BA-4C09-A819-0D2D167CA7D2 Q36909451-82D95BD0-B3E5-47F4-8B5E-10AB7B27A70F Q36997826-590F0267-769E-47A2-A84F-68485DBF6B79 Q37112462-2811A516-CE87-4676-A2D7-E044458DEA0B Q37626382-D35E9285-03A1-41E3-A997-56F11D2298EB Q38037157-9650D8F2-7F16-47CB-8FE9-AE7F475B92F6 Q38543843-489B19B5-9AA8-4550-BE11-ADF1D76227FC Q47155881-619A8B2F-0B3C-432B-B770-01F2C3364682 Q50745478-030BE736-1277-4692-AFAF-E8B17FF460ED Q51704620-63FD182A-2AB7-428D-9552-33B125746A2C Q52148328-477D215E-14B3-40EA-8366-37217B305C6C Q57495664-AA0F3E3F-E05D-478E-9B7B-F2866C6F8132

P2860

Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.

http://www.wikidata.org/entity/Q35601036

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Blood-based biomarkers for Alz ...... nd Aβ42, and genetic variants.

@ast

Blood-based biomarkers for Alz ...... nd Aβ42, and genetic variants.

@en

type

label

Blood-based biomarkers for Alz ...... nd Aβ42, and genetic variants.

@ast

Blood-based biomarkers for Alz ...... nd Aβ42, and genetic variants.

@en

prefLabel

Blood-based biomarkers for Alz ...... nd Aβ42, and genetic variants.

@ast

Blood-based biomarkers for Alz ...... nd Aβ42, and genetic variants.

@en

P1433

Q35601036-7676B398-C0E0-430D-81EA-BC1D0C04C6C7

P1476

Q35601036-7DBED103-4EE3-41E1-B13F-014CEB57E154

P2093

Q35601036-B803D087-0E39-4C91-B735-BD6FF8536B19

P2860

Q35601036-112FBA9D-0AB2-48B1-A376-50499658422F

Q35601036-13E8A15B-C8EE-4C3F-8260-2F5C2C2655A7

Q35601036-1515DE76-1D98-4714-8971-882462E53130

Q35601036-1DF42B51-F4D8-4F80-BBA1-811187A88974

Q35601036-1F40F2E7-74F9-4E12-A7F2-169F5AA5D263

Q35601036-1F63D6ED-F6D8-4CED-9E09-9DD5EA421BF7

Q35601036-2051636E-19A1-4323-B75F-3A9C91108A4D

Q35601036-22F1E0E4-AEC7-4362-B2E2-22C92EAA09C4

Q35601036-25DAD98A-DC84-459B-B1BB-CF626473D85F

Q35601036-283D8CC7-C302-4EA0-B331-2E1F3428CE6B

P304

Q35601036-29CF7392-2206-4F5D-B599-D1FD16EF6A64

P31

Q35601036-A348E03D-A7B1-4EF5-8B9C-AF59A3F39F27

P356

Q35601036-F2CB2C36-6537-4C35-A3E3-075F311AFCC4

P478

Q35601036-3B85338A-90B3-4335-84E3-A4758932125C

P50

Q35601036-E368B239-81E9-4E0B-89C1-E6B5123D0B6B

P577

Q35601036-6093BD14-AC17-4D67-BA3A-C8B6C336304F

P5875

Q35601036-6A0884D6-D416-404C-A8B1-50D50C406C51

P698

Q35601036-07503915-D917-476A-85CB-4A521FB64975

P921

Q35601036-44B4E91C-C560-4053-B5E1-F8BB854089BD

Q35601036-7C5E7729-F77E-4607-96CC-2FD68F8C8763

P932

Q35601036-CE87EA49-13B4-4BF7-9668-C23D8D3BA616

P356

J.NEUROBIOLAGING.2011.09.004

P1433

Neurobiology of Aging

P1476

Blood-based biomarkers for Alz ...... nd Aβ42, and genetic variants.

@en

P2093

Nicole Schupf

http://www.w3.org/2001/XMLSchema#string

P2860

Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease

Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

A specific amyloid-beta protein assembly in the brain impairs memory

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

P304

S10-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2011.09.004

http://www.w3.org/2001/XMLSchema#string

P478

32 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221717271

http://www.w3.org/2001/XMLSchema#string

P698

22078169

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3233700

http://www.w3.org/2001/XMLSchema#string